CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
---|---|---|---|---|---|---|
C20604 | BRD-K57155690 | BRD-K57155690 | -- | -- | -- | Details |
C20605 | BRD-K57166447 | BRD-K57166447 | -- | -- | -- | Details |
C20606 | BRD-K57167256 | BRD-K57167256 | -- | -- | -- | Details |
C20607 | BRD-K57169040 | BRD-K57169040 | -- | -- | -- | Details |
C20608 | BRD-K57169635 | dacomitinib | EGFR; ERBB2; ERBB4 | EGFR inhibitor | -- | Details |
C20609 | BRD-K57170492 | BRD-K57170492 | -- | -- | -- | Details |
C20610 | BRD-K57173429 | BRD-K57173429 | -- | -- | -- | Details |
C20611 | BRD-K57174586 | sertraline | SLC6A4 | Serotonin receptor antagonist | -- | Details |
C20612 | BRD-K57179401 | BRD-K57179401 | -- | -- | -- | Details |
C20613 | BRD-K57179821 | crotamiton | -- | -- | -- | Details |
C20614 | BRD-K57180092 | BRD-K57180092 | -- | -- | -- | Details |
C20615 | BRD-K57181059 | BRD-K57181059 | -- | -- | -- | Details |
C20616 | BRD-K57182060 | BRD-K57182060 | -- | -- | -- | Details |
C20617 | BRD-K57184082 | BRD-K57184082 | -- | -- | -- | Details |
C20618 | BRD-K57184137 | BRD-K57184137 | -- | -- | -- | Details |
C20619 | BRD-K57186295 | BRD-K57186295 | -- | -- | -- | Details |
C20620 | BRD-K57195030 | BRD-K57195030 | -- | -- | -- | Details |
C20621 | BRD-K57200229 | SD-6-035-B3 | -- | -- | -- | Details |
C20622 | BRD-K57200567 | BRD-K57200567 | -- | -- | -- | Details |
C20623 | BRD-K57202089 | BRD-K57202089 | -- | -- | -- | Details |
C20624 | BRD-K57204377 | BRD-K57204377 | -- | -- | -- | Details |
C20625 | BRD-K57204946 | BRD-K57204946 | -- | -- | -- | Details |
C20626 | BRD-K57205873 | BRD-K57205873 | -- | -- | -- | Details |
C20627 | BRD-K57206606 | BRD-K57206606 | -- | -- | -- | Details |
C20628 | BRD-K57207769 | BRD-K57207769 | -- | -- | -- | Details |
C20629 | BRD-K57216724 | BRD-K57216724 | -- | -- | -- | Details |
C20630 | BRD-K57218099 | BRD-K57218099 | -- | -- | -- | Details |
C20631 | BRD-K57218871 | BRD-K57218871 | -- | -- | -- | Details |
C20632 | BRD-K57222227 | indometacin | PTGDR2; PPARG; PTGS1; PTGS2 | Cyclooxygenase inhibitor | -- | Details |
C20633 | BRD-K57226184 | BRD-K57226184 | -- | -- | -- | Details |
C20634 | BRD-K57226763 | BRD-K57226763 | -- | -- | -- | Details |
C20635 | BRD-K57228212 | BRD-K57228212 | -- | -- | -- | Details |
C20636 | BRD-K57228329 | BRD-K57228329 | -- | -- | -- | Details |
C20637 | BRD-K57230817 | BRD-K57230817 | -- | -- | -- | Details |
C20638 | BRD-K57238941 | BRD-K57238941 | -- | -- | -- | Details |
C20639 | BRD-K57242481 | BRD-K57242481 | -- | -- | -- | Details |
C20640 | BRD-K57244822 | BRD-K57244822 | -- | -- | -- | Details |
C20641 | BRD-K57250790 | BRD-K57250790 | -- | -- | -- | Details |
C20642 | BRD-K57251296 | BRD-K57251296 | -- | -- | -- | Details |
C20643 | BRD-K57252450 | cilengitide | ITGAV; ITGB3 | Integrin inhibitor | -- | Details |
C20644 | BRD-K57261999 | marinopyrrole-a | -- | -- | -- | Details |
C20645 | BRD-K57262525 | BRD-K57262525 | -- | -- | -- | Details |
C20646 | BRD-K57270624 | BRD-K57270624 | -- | -- | -- | Details |
C20647 | BRD-K57271749 | BRD-K57271749 | -- | -- | -- | Details |
C20648 | BRD-K57272712 | BRD-K57272712 | -- | -- | -- | Details |
C20649 | BRD-K57274378 | BRD-K57274378 | -- | -- | -- | Details |
C20650 | BRD-K57275439 | BRD-K57275439 | -- | -- | -- | Details |
C20651 | BRD-K57277442 | BRD-K57277442 | -- | -- | -- | Details |
C20652 | BRD-K57280824 | BRD-K57280824 | -- | -- | -- | Details |
C20653 | BRD-K57282030 | JW-7-24-1 | -- | -- | -- | Details |
C20654 | BRD-K57285282 | JAS07-006 | -- | -- | JAS-07-006 | Details |
C20655 | BRD-K57286317 | BRD-K57286317 | -- | -- | -- | Details |
C20656 | BRD-K57291914 | moroxydine | -- | -- | -- | Details |
C20657 | BRD-K57293132 | BRD-K57293132 | -- | -- | -- | Details |
C20658 | BRD-K57293986 | BRD-K57293986 | -- | -- | -- | Details |
C20659 | BRD-K57304726 | PRE-084 | SIGMAR1 | Sigma receptor agonist | -- | Details |
C20660 | BRD-K57308809 | BRD-K57308809 | -- | -- | -- | Details |
C20661 | BRD-K57309821 | BRD-K57309821 | -- | -- | -- | Details |
C20662 | BRD-K57315740 | BRD-K57315740 | -- | -- | -- | Details |
C20663 | BRD-K57321627 | BRD-K57321627 | -- | -- | -- | Details |
C20664 | BRD-K57323824 | BRD-K57323824 | -- | -- | -- | Details |
C20665 | BRD-K57328348 | BRD-K57328348 | -- | -- | -- | Details |
C20666 | BRD-K57330428 | BRD-K57330428 | -- | -- | -- | Details |
C20667 | BRD-K57337567 | BRD-K57337567 | -- | -- | -- | Details |
C20668 | BRD-K57339160 | BRD-K57339160 | -- | -- | -- | Details |
C20669 | BRD-K57341983 | BRD-K57341983 | -- | -- | -- | Details |
C20670 | BRD-K57342930 | BRD-K57342930 | -- | -- | -- | Details |
C20671 | BRD-K57343972 | BRD-K57343972 | -- | -- | -- | Details |
C20672 | BRD-K57345537 | BRD-K57345537 | -- | -- | -- | Details |
C20673 | BRD-K57346283 | BRD-K57346283 | -- | -- | -- | Details |
C20674 | BRD-K57346660 | BRD-K57346660 | -- | -- | -- | Details |
C20675 | BRD-K57349002 | BRD-K57349002 | -- | -- | -- | Details |
C20676 | BRD-K57350811 | BRD-K57350811 | -- | -- | -- | Details |
C20677 | BRD-K57351233 | BRD-K57351233 | -- | -- | -- | Details |
C20678 | BRD-K57353465 | BRD-K57353465 | -- | -- | -- | Details |
C20679 | BRD-K57356416 | BRD-K57356416 | -- | -- | -- | Details |
C20680 | BRD-K57357304 | BRD-K57357304 | -- | -- | -- | Details |
C20681 | BRD-K57357721 | BRD-K57357721 | -- | -- | -- | Details |
C20682 | BRD-K57359365 | BRD-K57359365 | -- | -- | -- | Details |
C20683 | BRD-K57364182 | BRD-K57364182 | -- | -- | -- | Details |
C20684 | BRD-K57365604 | BRD-K57365604 | -- | -- | -- | Details |
C20685 | BRD-K57371454 | BRD-K57371454 | -- | -- | -- | Details |
C20686 | BRD-K57371763 | fidaxomicin | -- | -- | -- | Details |
C20687 | BRD-K57375725 | BRD-K57375725 | -- | -- | -- | Details |
C20688 | BRD-K57382977 | BRD-K57382977 | -- | -- | 2-{2-[(1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino]ethoxy}ethanol | Details |
C20689 | BRD-K57388326 | BRD-K57388326 | -- | -- | -- | Details |
C20690 | BRD-K57389835 | BRD-K57389835 | -- | -- | -- | Details |
C20691 | BRD-K57391913 | iloprost | PTGER1; PTGER2; PTGIR | Prostanoid receptor agonist; Platelet aggregation inhibitor | -- | Details |
C20692 | BRD-K57393707 | BRD-K57393707 | -- | -- | -- | Details |
C20693 | BRD-K57397611 | BRD-K57397611 | -- | -- | -- | Details |
C20694 | BRD-K57404319 | BRD-K57404319 | -- | -- | -- | Details |
C20695 | BRD-K57406954 | BRD-K57406954 | -- | -- | -- | Details |
C20696 | BRD-K57408604 | BRD-K57408604 | -- | -- | -- | Details |
C20697 | BRD-K57420195 | BRD-K57420195 | -- | -- | -- | Details |
C20698 | BRD-K57427145 | ripazepam | -- | -- | -- | Details |
C20699 | BRD-K57432881 | tiapride | DRD2; DRD3 | Dopamine receptor antagonist | -- | Details |
C20700 | BRD-K57441129 | BRD-K57441129 | -- | -- | -- | Details |
C20701 | BRD-K57443339 | BRD-K57443339 | -- | -- | -- | Details |
C20702 | BRD-K57443386 | BRD-K57443386 | -- | -- | -- | Details |
C20703 | BRD-K57457519 | BRD-K57457519 | -- | -- | -- | Details |